Despite major advances in dermatology, psoriasis continues to pose diagnostic and therapeutic challenges, often requiring ...

The global psoriasis treatment market is projected to expand at a compound annual growth rate (CAGR) of 8.5% by 2026. Key factors fueling this growth include the rising prevalence of psoriasis, ...

A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the ...

Discover key truths about psoriasis, from symptoms and causes to effective management strategies to improve your quality of ...

The Psoriasis Treatment Market is experiencing significant growth, driven by several factors including the rising prevalence of psoriasis, increased awareness, advancements in treatment options, and ...

Shane Brouse has learned that psoriasis is more than a skin condition. The effects can be debilitating for some. When it ...

Arctic Bioscience AS ( ($DE:9TD) ) just unveiled an announcement. Arctic Bioscience’s recent analysis from the HeROPA study indicates that their ...

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with ...

On October 29th, the global community observes World Psoriasis Day, raising awareness about this chronic skin condition that affects millions. With over 5 million individuals in Brazil alone impacted ...

SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...